Cargando…
Albumin redox state of maintenance haemodialysis patients is positively altered after treatment
BACKGROUND AND AIM: Maintenance haemodialysis patients have increased morbidity and mortality which is mainly driven by an elevated inflammation level due to the uraemic milieu. A major part of this increased inflammation level is the degree of oxidative stress which can be assessed by albumin redox...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506191/ https://www.ncbi.nlm.nih.gov/pubmed/37723426 http://dx.doi.org/10.1186/s12882-023-03317-9 |
_version_ | 1785107067902623744 |
---|---|
author | Boss, Kristina Paar, Margret Waterstradt, Katja Schnurr, Kerstin Ickerott, Philipp Wieneke, Ulrike Spitthöver, Ralf Oettl, Karl Kribben, Andreas |
author_facet | Boss, Kristina Paar, Margret Waterstradt, Katja Schnurr, Kerstin Ickerott, Philipp Wieneke, Ulrike Spitthöver, Ralf Oettl, Karl Kribben, Andreas |
author_sort | Boss, Kristina |
collection | PubMed |
description | BACKGROUND AND AIM: Maintenance haemodialysis patients have increased morbidity and mortality which is mainly driven by an elevated inflammation level due to the uraemic milieu. A major part of this increased inflammation level is the degree of oxidative stress which can be assessed by albumin redox state (ARS). Aim of this study was to evaluate how the ARS is affected by a haemodialysis treatment and different dialyzer properties. METHODS: ARS was determined before and after haemodialysis treatment by fractionating it into reduced human mercaptalbumin (HMA), reversibly oxidized human non-mercaptalbumin 1 (HNA-1), and irreversibly oxidized human non-mercaptalbumin 2 (HNA-2) by high-performance liquid chromatography. In healthy individuals, albumin circulates in the following proportions: HMA 70–80%, HNA-1 20–30% and HNA-2 2–5%. High flux (FX 100 [Fresenius Medical Care], BG 1.8 [Toray], Xevonta Hi 18 [B. Braun], CTA-2000 [Kawasumi]) and low flux FX10 [Fresenius Medical Care] dialyzers were used. RESULTS: 58 patients (59% male, median age 68 years, median time on haemodialysis 32 month) were included in the study. Before haemodialysis treatment, HMA (median 55.9%, IQR 50.1–61.2%) was substantially lower than in healthy individuals. Accordingly, oxidized albumin fractions were above the level of healthy individuals (median HNA-1 38.5%, IQR 33.3–43.2%; median HNA-2 5.8%, IQR 5.1–6.7%). Before haemodialysis treatment HMA was significantly higher in patients usually treated with high flux membranes (p < 0.01). After haemodialysis treatment there was a significant increase of HMA and a decrease of HNA-1 and HNA-2 (p < 0.01). These effects were more pronounced in patients treated with high flux dialyzers (p < 0.01). There were no differences of ARS alteration with regard to the dialyzer´s sterilization mode or the presence of diabetes. CONCLUSION: The study confirms that the ARS is positively altered by haemodialysis and shows for the first time that this effect depends on dialyzer properties. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03317-9. |
format | Online Article Text |
id | pubmed-10506191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105061912023-09-19 Albumin redox state of maintenance haemodialysis patients is positively altered after treatment Boss, Kristina Paar, Margret Waterstradt, Katja Schnurr, Kerstin Ickerott, Philipp Wieneke, Ulrike Spitthöver, Ralf Oettl, Karl Kribben, Andreas BMC Nephrol Research BACKGROUND AND AIM: Maintenance haemodialysis patients have increased morbidity and mortality which is mainly driven by an elevated inflammation level due to the uraemic milieu. A major part of this increased inflammation level is the degree of oxidative stress which can be assessed by albumin redox state (ARS). Aim of this study was to evaluate how the ARS is affected by a haemodialysis treatment and different dialyzer properties. METHODS: ARS was determined before and after haemodialysis treatment by fractionating it into reduced human mercaptalbumin (HMA), reversibly oxidized human non-mercaptalbumin 1 (HNA-1), and irreversibly oxidized human non-mercaptalbumin 2 (HNA-2) by high-performance liquid chromatography. In healthy individuals, albumin circulates in the following proportions: HMA 70–80%, HNA-1 20–30% and HNA-2 2–5%. High flux (FX 100 [Fresenius Medical Care], BG 1.8 [Toray], Xevonta Hi 18 [B. Braun], CTA-2000 [Kawasumi]) and low flux FX10 [Fresenius Medical Care] dialyzers were used. RESULTS: 58 patients (59% male, median age 68 years, median time on haemodialysis 32 month) were included in the study. Before haemodialysis treatment, HMA (median 55.9%, IQR 50.1–61.2%) was substantially lower than in healthy individuals. Accordingly, oxidized albumin fractions were above the level of healthy individuals (median HNA-1 38.5%, IQR 33.3–43.2%; median HNA-2 5.8%, IQR 5.1–6.7%). Before haemodialysis treatment HMA was significantly higher in patients usually treated with high flux membranes (p < 0.01). After haemodialysis treatment there was a significant increase of HMA and a decrease of HNA-1 and HNA-2 (p < 0.01). These effects were more pronounced in patients treated with high flux dialyzers (p < 0.01). There were no differences of ARS alteration with regard to the dialyzer´s sterilization mode or the presence of diabetes. CONCLUSION: The study confirms that the ARS is positively altered by haemodialysis and shows for the first time that this effect depends on dialyzer properties. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03317-9. BioMed Central 2023-09-18 /pmc/articles/PMC10506191/ /pubmed/37723426 http://dx.doi.org/10.1186/s12882-023-03317-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Boss, Kristina Paar, Margret Waterstradt, Katja Schnurr, Kerstin Ickerott, Philipp Wieneke, Ulrike Spitthöver, Ralf Oettl, Karl Kribben, Andreas Albumin redox state of maintenance haemodialysis patients is positively altered after treatment |
title | Albumin redox state of maintenance haemodialysis patients is positively altered after treatment |
title_full | Albumin redox state of maintenance haemodialysis patients is positively altered after treatment |
title_fullStr | Albumin redox state of maintenance haemodialysis patients is positively altered after treatment |
title_full_unstemmed | Albumin redox state of maintenance haemodialysis patients is positively altered after treatment |
title_short | Albumin redox state of maintenance haemodialysis patients is positively altered after treatment |
title_sort | albumin redox state of maintenance haemodialysis patients is positively altered after treatment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506191/ https://www.ncbi.nlm.nih.gov/pubmed/37723426 http://dx.doi.org/10.1186/s12882-023-03317-9 |
work_keys_str_mv | AT bosskristina albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment AT paarmargret albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment AT waterstradtkatja albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment AT schnurrkerstin albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment AT ickerottphilipp albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment AT wienekeulrike albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment AT spitthoverralf albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment AT oettlkarl albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment AT kribbenandreas albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment |